Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KITE-PWS: RGH-706 in Prader-Willi Syndrome
NCT05322096Phase 2Completed
- Sponsor
- Gedeon Richter Plc
- Start
- Sep 2022
- Primary completion
- Apr 2024
- Modality
- Small Molecules
- Countries
- 5
01
Overview
Phase 2, randomised, double-blind trial in Prader-Willi syndrome (PWS) comparing RGH-706 with Placebo (2 arms). Started Sep 2022; status: completed.
02
Drugs
rgh-706
03
Conditions
Prader-Willi syndrome (PWS)
Beyond the preview
Go deeper on NCT05322096.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05322096.